1Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan.
2Graduate Institute of Business Administration, College of Management, and.
J Natl Compr Canc Netw. 2022 Dec;20(12):1299-1306.e2. doi: 10.6004/jnccn.2022.7063.
Whether preexisting sarcopenia is an independent risk factor for postoperative pneumonia (POP) for patients with oral cavity squamous cell carcinoma (OCSCC) remains unclear. Therefore, we conducted a propensity score-matched population-based cohort study to compare the risk of acute and late POP for patients with sarcopenic and nonsarcopenic OCSCC who underwent curative surgery.
We included patients with OCSCC who underwent curative surgery and categorized them into 2 groups depending on whether they had preexisting sarcopenia. The patients in the sarcopenic and nonsarcopenic groups were matched at a ratio of 2:1.
The matching process yielded 16,257 patients (10,822 without sarcopenia and 5,435 with sarcopenia). In multivariate Cox regression analyses, the adjusted hazard ratio of POP for the group with OCSCC with preexisting sarcopenia was 1.20 (95% CI, 1.14-1.26; P<.0001) compared with the nonsarcopenic group. Among the patients with OCSCC who received curative surgery, those in the sarcopenic group exhibited a higher POP risk than those in the nonsarcopenic group for the following postoperative time periods: 31st to 90th day, 91st day to first year, first to second year, second to third year, third to fourth year, and fourth to fifth year.
The high incidence of pneumonia persists for a long time in patients with OCSCC who receive curative surgery; this high incidence may even persist for 5 years after surgery, especially in patients with sarcopenia. For susceptible patients who are at risk for OCSCC, sarcopenia prevention measures (eg, exercise and early nutrition intervention) should be implemented.
口腔鳞状细胞癌(OCSCC)患者术前是否存在肌少症仍是术后肺炎(POP)的独立危险因素尚不明确。因此,我们开展了一项基于倾向评分匹配的人群队列研究,以比较接受根治性手术的肌少症和非肌少症 OCSCC 患者的急性和迟发性 POP 风险。
我们纳入了接受根治性手术的 OCSCC 患者,并根据是否存在术前肌少症将其分为 2 组。肌少症和非肌少症组按 2:1 的比例进行匹配。
匹配过程得到 16257 例患者(非肌少症 10822 例,肌少症 5435 例)。多变量 Cox 回归分析显示,与非肌少症组相比,术前存在肌少症的 OCSCC 患者 POP 的调整后危险比为 1.20(95%CI,1.14-1.26;P<.0001)。在接受根治性手术的 OCSCC 患者中,与非肌少症组相比,肌少症组在以下术后时间点的 POP 风险更高:第 31-90 天、第 91 天至第 1 年、第 1 年至第 2 年、第 2 年至第 3 年、第 3 年至第 4 年和第 4 年至第 5 年。
接受根治性手术的 OCSCC 患者的肺炎发病率高且持续时间长;这种高发病率甚至可能在手术后 5 年内持续存在,尤其是在肌少症患者中。对于存在 OCSCC 风险的易感患者,应采取肌少症预防措施(如运动和早期营养干预)。